Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/21
End: 06/23/22
Due: 06/23/23
Phase: N/A
Priority: Normal
Start: 10/21/21
End: 05/26/23
Due: 05/26/24
Phase: N/A
Priority: Normal
Start: 07/15/21
End: 06/30/23
Due: 06/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS | NCT04852419 | Zentera Therapeutics HK Limited | user2@example.com | None | 2021-05-31 | 2022-06-23 | 2023-06-23 | - | - | 2025-07-14 |
| A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma | NCT05127811 | Zentera Therapeutics HK Limited | user2@example.com | None | 2021-10-21 | 2023-05-26 | 2024-05-26 | - | - | 2025-07-14 |
| A Phase 1b Study of ZN-c3 in Chinese Subjects | NCT04972422 | Zentera Therapeutics HK Limited | user2@example.com | None | 2021-07-15 | 2023-06-30 | 2024-06-30 | - | - | 2025-07-14 |